Inflammation as a Predictor in Cardioversion of Atrial Fibrillation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-10-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The laboratory test, C-Reactive Protein (CRP), has become well established as a marker of inflammation. Recently a high CRP level (indicating an increase in inflammation) was identified as a risk factor for atrial fibrillation. We are conducting this study with patients such as yourself with atrial fibrillation who are planning to undergo cardioversion to determine what sort of relationship exists between CRP levels and atrial fibrillation. We will then look at success rates of converting atrial fibrillation to normal sinus rhythm, compared to patients' CRP levels.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Inflammation Markers Over Time in Cardiovascular Disease

NCT00005692

Cardiovascular Diseases Coronary Disease Heart Diseases +2 more

COMPLETED

Inflammation, Infection, and Future Cardiovascular Risk

NCT00005496

Cardiovascular Diseases Coronary Disease Cerebrovascular Accident +9 more

COMPLETED

Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure

NCT00542659

Atrial Fibrillation

COMPLETED

Genetic Markers of CHD Risk in Men and Women

NCT00090454

Cardiovascular Diseases Coronary Disease Heart Diseases +2 more

COMPLETED

Inflammatory Genomics in Human Carotid Artery Disease

NCT00070668

Cardiovascular Diseases Atherosclerosis Carotid Artery Diseases +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Cardioversion

Intervention Type PROCEDURE

Baseline hsCRP will be drawn the morning of, prior to, cardioversion. An EKG to document the patient's rhythm will be obtained at the one-month mark

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardioversion

Baseline hsCRP will be drawn the morning of, prior to, cardioversion. An EKG to document the patient's rhythm will be obtained at the one-month mark

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Atrial fibrillation patients referred for DC cardioversion
* On stable medical therapy

Exclusion Criteria

* Known chronic inflammatory states such as infections, rheumatoid arthritis or known vasculitides.
* Patients having undergone recent surgery or who are on steroid therapy for any reason will be excluded.

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No